Literature DB >> 22773996

Meta analysis on the relationship between gene polymorphisms of vascular endothelial growth factor and retinal prognosis risk of prematurity.

Jun Zhai1, Qiu-Hui Jiang, Chun-Xi Liu, Zuo-Rong Tian, Ying-Pu Sun.   

Abstract

AIM: To explore the relationship between gene polymorphisms of vascular endothelial growth factor (VEGF) and retinopathy of prematurity (ROP).
METHODS: Literature materials related to gene polymorphisms of VEGF and ROP in PubMed, EMBASE, Cochrane and CBM database were retrieved. These materials were screened according to inclusion and exclusion standards. Patients diagnosed with ROP in clinic were regarded as control group and ROP patients who were in treatment were regarded as observation group. The indexes in two groups were matched except birth weight (BW), gender and gestational weeks. Meta5.1 was used to analyze the relationship between gene polymorphisms of VEGF and ROP.
RESULTS: Four random control tests (RCT) were included in this research, including 2611 patients. Meta analysis results showed that VEGF affected ROP, having statistical significance. The combined ratio was 0.44 (95%CI, 0.07, 0.80), 0.42 (95%CI, 0.09, 0.74) and 0.75 (95%CI, 0.02, 1.49), respectively. Carrying +405 allele might increase the premature infants' risk of having ROP.
CONCLUSION: ROP may be related to its carrying of +405 allele. Large-scale, multi-factor RCT researches are still needed in order to identify the relation between VEGF and ROP.

Entities:  

Keywords:  Meta analysis; polymorphisms of vascular endothelial growth factor; premature infant; retinopathy

Year:  2012        PMID: 22773996      PMCID: PMC3388416          DOI: 10.3980/j.issn.2222-3959.2012.03.29

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  18 in total

1.  Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production.

Authors:  C J Watson; N J Webb; M J Bottomley; P E Brenchley
Journal:  Cytokine       Date:  2000-08       Impact factor: 3.861

2.  Lack of association of the VEGF gene promoter (-634 G-->C and -460 C-->T) polymorphism and the risk of advanced retinopathy of prematurity.

Authors:  Barkur S Shastry; Xianggui Qu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-22       Impact factor: 3.117

3.  Published genetic variants in retinopathy of prematurity: random forest analysis suggests a negligible contribution to risk and severity.

Authors:  György Dunai; Barna Vásárhelyi; Miklós Szabó; Júlia Hajdú; Gergõ Mészáros; Tivadar Tulassay; András Treszl
Journal:  Curr Eye Res       Date:  2008-05       Impact factor: 2.424

4.  Retinopathy of prematurity in middle-income countries.

Authors:  C Gilbert; J Rahi; M Eckstein; J O'Sullivan; A Foster
Journal:  Lancet       Date:  1997-07-05       Impact factor: 79.321

5.  A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels.

Authors:  W Renner; S Kotschan; C Hoffmann; B Obermayer-Pietsch; E Pilger
Journal:  J Vasc Res       Date:  2000 Nov-Dec       Impact factor: 1.934

6.  Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy.

Authors:  M L Donahue; D L Phelps; R H Watkins; M B LoMonaco; S Horowitz
Journal:  Curr Eye Res       Date:  1996-02       Impact factor: 2.424

7.  A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes.

Authors:  Takuya Awata; Kiyoaki Inoue; Susumu Kurihara; Tomoko Ohkubo; Masaki Watanabe; Kouichi Inukai; Ikuo Inoue; Shigehiro Katayama
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

8.  The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity.

Authors:  Przemko Kwinta; Mirosław Bik-Multanowski; Zofia Mitkowska; Tomasz Tomasik; Jacek J Pietrzyk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117

9.  The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates.

Authors:  T Murata; K Nakagawa; A Khalil; T Ishibashi; H Inomata; K Sueishi
Journal:  Lab Invest       Date:  1996-01       Impact factor: 5.662

Review 10.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

Authors:  H F Dvorak; L F Brown; M Detmar; A M Dvorak
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.